Get the Stockscreener App
54.80
3.08%
-1.74
Bruker Corp stock is traded at $54.80, with a volume of 1.67M.
It is down -3.08% in the last 24 hours and down -9.68% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$56.54
Open:
$56.45
24h Volume:
1.67M
Relative Volume:
0.76
Market Cap:
$8.35B
Revenue:
$3.46B
Net Income/Loss:
$-9.40M
P/E Ratio:
-227.95
EPS:
-0.2404
Net Cash Flow:
$51.30M
1W Performance:
-6.87%
1M Performance:
-9.68%
6M Performance:
+40.73%
1Y Performance:
+43.46%
1-Day Range:
$54.27
$57.18
1-Week Range:
$54.27
$58.75
52-Week Range:
$32.37
$66.98
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
54.80 | 8.35B | 3.46B | -9.40M | 51.30M | -0.2404 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-09-26 | Initiated | UBS | Neutral |
| Jun-02-26 | Resumed | Wolfe Research | Peer Perform |
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-09-25 | Initiated | Goldman | Sell |
| Nov-20-25 | Initiated | Rothschild & Co Redburn | Buy |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker Gains 66.3% in a Year: What's Driving the Rally? - Zacks Investment Research
Bruker announces proteome atlas: Bruker stock gains 1.14 percent - AD HOC NEWS
Bruker Corp (BRKR) Shares Fall 5.3% -- GF Value Says Still Overv - GuruFocus
Bruker Drops 6.5% Amid Sector-Wide Selling - AlphaStreet
Bruker (NASDAQ:BRKR) Stock Price Down 6.5%Time to Sell? - MarketBeat
Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution - Business Wire
Bruker stock adds a USD 6 million UC Berkeley order - AD HOC NEWS
Bruker Corporation (BRKR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Are Options Traders Betting on a Big Move in Bruker Stock? - TradingView
Are Options Traders Betting on a Big Move in Bruker Stock? - Zacks Investment Research
Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley - Moomoo
Bruker Stock Price Forecast. Should You Buy BRKR? - StockInvest.us
Why Bruker (BRKR) is a Top Momentum Stock for the Long-Term - Zacks Investment Research
Bruker Corp (BRKR) Shares Fall 4.3% -- GF Value Says Still Overv - GuruFocus
Bruker Slides as No Fresh Catalyst Emerges and Broader Risk-Off Mood Weighs - Quiver Quantitative
Bruker Corporation (BRKR) Stock Forecasts - Yahoo Finance
Bruker (NASDAQ:BRKR) Sets New 52-Week HighShould You Buy? - MarketBeat
Bruker Corporation stock hits 52-week high at 65.48 USD By Investing.com - Investing.com South Africa
Bruker Corporation stock hits 52-week high at 65.48 USD - Investing.com
Bruker (BRKR) Sets a New 52-Week High at $64.51 - 24/7 Wall St.
Long term debt to total assets ratio of Bruker Corporation – HAN:BKD - TradingView
Total liabilities & shareholders' equities of Bruker Corporation – HAN:BKD - TradingView
Bruker Corporation (BRKRP) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bruker (BRKR) Unveils Advanced Protein-Sequence Analysis Workflo - GuruFocus
Bruker Corporation Announces New Timsultra Aip and Timsomni Workflows for Drug Discovery and Development and Disease Biology Research - marketscreener.com
Bruker unveils proteomics workflows at HUPO congress - Investing.com
MA-BRUKER-CORPORATION - The Facts
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research - Rutland Herald
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research - bdtonline.com
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research - Business Wire
BRKR 10-Q FilingsBruker Corporation SEC 10-Q - Stock Titan
Bruker Sees AI-Fueled Semiconductor Demand, Targets Critical Q4 Revenue Rebound - Yahoo Finance
Bruker (BRKR) surges nearly 10% in a single session - 24/7 Wall St.
Bruker Corporation (BRKR) Stock Forecasts - Yahoo Finance
Automated Microscopy Market Advances as AI-Powered Image Analysis Transforms Digital Pathology and Semiconductor Inspection - GlobeNewswire Inc.
Global Metabolomics Market to Reach US$9.01 Billion by 2035 as Precision Medicine, Biomarker Discovery and Advanced Analytics Unlock New Opportunities - GlobeNewswire Inc.
Is Bruker (BRKR) Using Flagship Academic NMR Deals To Deepen Its High-End Moat? - Yahoo Finance
Bruker Gets More Than $6 Million Order From University of California, Berkeley - Yahoo Finance
55,937 Shares in Bruker Corporation $BRKR Purchased by Squarepoint Ops LLC - MarketBeat
Bruker Corporation at Wells Fargo Healthcare Conference Transcript - GuruFocus
Wellington Management Group LLP Invests $1.36 Million in Bruker Corporation $BRKR - MarketBeat
Can Bruker (BRKR) Stay Below Fair Value After Fusion News? - simplywall.st
Bruker advances whole-organism 3D imaging with enhanced tissue-clearing workflows - News-Medical
Bruker Corp (BRKR) Shares Fall 6.8% -- What GF Score of 86 Tells Investors - GuruFocus
Bruker Corporation at Wells Fargo Healthcare Conference Transcript - GuruFocus
UBS Adjusts Bruker Price Target to $65 From $45, Maintains Neutral Rating - Moomoo
Why Bruker (BRKR) Stock Is Falling Today - Yahoo Finance
Bruker (NASDAQ:BRKR) Shares Down 7.1%Time to Sell? - MarketBeat
UBS Group Begins Coverage on Bruker (NASDAQ:BRKR) - MarketBeat
Bruker at Wells Fargo Healthcare Conference: deep tech drives growth - investing.com
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bruker Corp Stock (BRKR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| MARK R MUNCH | Officer |
Sep 15 '26 |
Proposed Sale |
52.87 |
2,000 |
105,740 |
0 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Sep 15 '26 |
Sale |
52.87 |
2,000 |
105,740 |
134,806 |
| Pusch Wolfgang | President BMID Group |
Aug 17 '26 |
Sale |
56.90 |
3,473 |
197,614 |
9,801 |
| WOLFGANG PUSCH | Officer |
Aug 17 '26 |
Proposed Sale |
56.90 |
3,473 |
197,614 |
0 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Aug 14 '26 |
Option Exercise |
22.19 |
2,000 |
44,380 |
125,347 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Aug 14 '26 |
Sale |
57.60 |
2,000 |
115,200 |
123,347 |
| MARK R MUNCH | Officer |
Aug 14 '26 |
Proposed Sale |
57.60 |
2,000 |
115,200 |
0 |
| MARK R MUNCH | Officer |
Jul 15 '26 |
Proposed Sale |
60.25 |
2,000 |
120,500 |
0 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Jul 15 '26 |
Option Exercise |
22.19 |
2,000 |
44,380 |
130,443 |
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Jul 15 '26 |
Sale |
60.25 |
2,000 |
120,500 |
128,443 |
3.49%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):